Showing results (31-40 of 432) with videos related to
Sort By:
Pageof 44
Best Practice & Research. Clinical Endocrinology & Metabolism|June 14, 2011
Adipose tissue biology and HIV-infectionMarta Giralt, Pere Domingo, Francesc VillarroyaTrends in Pharmacological Sciences|February 1, 2005
Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicityFrancesc Villarroya, Pere Domingo, Marta GiraltPPAR Research|December 17, 2008
HIV-1 infection and the PPARγ-dependent control of adipose tissue physiologyMarta Giralt, Pere Domingo, Francesc VillarroyaCurrent Opinion in HIV and AIDS|April 18, 2009
Mechanisms of antiretroviral-induced mitochondrial dysfunction in adipocytes and adipose tissue: in-vitro, animal and human adipose tissue studiesFrancesc Villarroya, Pere Domingo, Marta GiraltClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2025
A plague like no other: beyond the buboes in Thucydides' account of the Plague of AthensPere Domingo, Paula Prieto, Lluis PonsCytokine|February 23, 2018
Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy (cART). A sub-study of a randomized, double-blind, placebo-controlled studyPere Domingo, José Miguel Gallego-Escuredo, Irene Fernández, et al.Clinical Nutrition (Edinburgh, Scotland)|June 27, 2017
Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled studyPere Domingo, Irene Fernández, José Miguel Gallego-Escuredo, et al.AIDS (London, England)|April 24, 2018
Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemiaPere Leyes, Montserrat Cofan, Ana González-Cordón, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 14, 2014
A 48-week study of fat molecular alterations in HIV naive patients starting tenofovir/emtricitabine with lopinavir/ritonavir or efavirenzPere Domingo, Maria del Mar Gutierrez, José Miguel Gallego-Escuredo, et al.AIDS (London, England)|January 2, 2007
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patientsLidia Ruiz, Roger Paredes, Guadalupe Gómez, et al.Pageof 44